Table 1a.
Reference | Material | Antibiotic | Tx Time | Controls | Sample Size | Cultures | Primary Findings |
---|---|---|---|---|---|---|---|
(Itokazu et al., 1997) | Fibrin | Arbekacin sulfate (ABK) | 13 wk | PBO, Untreated | 6 | Ground bone | Fibrin + ABK significantly reduced CFU vs. controls |
(Mader et al., 2002) | Fibrin | Tobramycin | 4 wk | Systemic tobramycin, PMMA, PBO, Untreated | 15 | Vortex bone chips & marrow | Fibrin, PMMA and systemic tobramycin had similar CFU counts; PMMA had the highest (−) culture rate |
(Mendel et al., 2005) | Collagen | Gentamicin | 4 wk | Systemic cefazolin (cef), PMMA +/− sys. cef., Collagen +/− sys. cef., Untreated | 10–12 | Ground bone | All Tx reduced CFU vs. untreated. Systemic cef. tended to additively augment local Tx. Collagen had 82% (−) cultures vs. 0% with PMMA |
(Cevher et al., 2006; Orhan et al., 2006) | Chitosan or Pectin microspheres | Ciprofloxacin | 3 wk | Systemic ciprofloxacin (cipro), PBO | 8 | Ground bone | Significant reduction in CFU by chitosan, but not pectin, vs. sys cipro; sys cipro was not different from PBO |
(Stinner et al., 2010) | Chitosan sponge | Vancomycin | 42 hr | Untreated | 5 | None | Vancomycin-chitosan sponge reduced bioluminescence of bacteria after 42 hrs of Tx |
(Xing et al., 2013) | Alginate beads in fibrin gel | Vancomycin | 3 mo | PBO | 3 | Biopsies in culture broth | 100% (−) cultures for Vanco-beads vs. 0% for PBO; Tx improved radiographic scores. |
PBO – Placebo (material without antibiotics); (−) – negative; Tx – treatment; sys – systemic